Five complexes containing N,N-bis(2-hydroxyethyl)-ethylenediamine with tetracyanidopalladate(II): synthesis, crystal structures, thermal, magnetic, and catalytic properties

Metalo components exhibiting significant anticancer and antibacterial properties: a novel sandwich-type like polymeric structure

Four new dicyanoargentate(I)-based complexes 1-4 were synthesized from certain metal ions with a tetradentate ligand [N, N-bis (2-hydroxyethyl) -ethylenediamine; N-bishydeten] and determined by diverse procedures (elemental, thermal, FT-IR, ESI-MS for 1-3 and, magnetic susceptibility and EPR for 1, and 2) including crystal analysis of 4. The crystal method revealed that complex 4 has a sandwich-type like polymeric chemical structure with layers formed by [Cd(N-bishydeten)2]2+ cations and [Ag(CN)2]- anions. The complexes were further characterized by fluorescence and UV spectroscopy to determine their physicochemical features. The complexes displayed a DNA binding activity within the same range as found for cisplatin, in addition to their strong stability in the presence of the physiological buffer system. The complexes were also investigated for pharmacological properties like interaction with DNA/Bovine serum albumin, anticancer and antibacterial activities. Physicochemical studies of DNA with the complexes suggested that the interaction mode between them are possibly both intercalative and groove binding types. These spectroscopic measurements also show that there may be a binding tendency between BSA and the complexes via hydrogen or Van der Waals bonds. The viability tests demonstrated that all the complexes exhibited antibacterial (1-4) and anticancer effects (2-4) toward ten diverse bacterial strains and three tumor cells (HT-29 colon adenocarcinoma, HeLa cervical cancer, and C6 glioma), respectively.

New bimetallic dicyanidoargentate(I)-based coordination compounds: Synthesis, characterization, biological activities and DNA-BSA binding affinities

Four compounds -two (2 and 3) completely new- of composition [Ni(edbea)Ag₃(CN)₅] (1), [Cu(edbea)Ag₂(CN)₄]·H₂O (2), [Cd(edbea)Ag₃(CN)₅]·H₂O (3) and [Cd(edbea)₂] [Ag(CN)₂]₂·H₂O (4) {edbea; 2,2'-(ethylenedioxy)bis (ethylamine)}, were synthesized and characterized using elemental, FT-IR, X-Ray (4), thermal, variable temperature magnetic measurement (1 and 2) and biological techniques. The DNA/BSA binding affinities of 2 and 3 were evaluated by UV-Vis spectrophotometric titrations, ethidium bromide exchange experiments and electrophoretic mobility measurements. Compounds 1 and 4 have previously been characterized and shown to reduce the proliferation and migration of tumor cells. For the sake of clarity, 1 precise mechanism of action on microbial organisms and temperature magnetic measurement were determined. The crystallographic analyses showed that 4 was built up of [Cd(edbea)₂]^II cations and [Ag₂(CN)₄]^II anions. Complexes demonstrated a remarkable antibacterial (1-4), antifungal (1-4) and antiproliferative activities (2 and 3) to ten human bacterial pathogens, four plant pathogenic fungi or three tumor cells (HeLa, HT29, and C6), respectively. Therefore, our results strongly confirm that cell proliferation, cell morphology, Bcl-2, P53 changes and apoptosis can be related to the pharmacological effects of the complexes as suitable candidate for clinical trials.

Five novel dicyanidoaurate(i)-based complexes exhibiting significant biological activities: synthesis, characterization and three crystal structures

Herein the anticancer, antibacterial, and antifungal effects of the five novel dicyanidoaurate(i)-based complexes have been reported.

CH⋯Pd interactions: one dimensional heteropolynuclear complexes

Three cyanide complexes, [Cu(hepH)2Pd(μ-CN)2(CN)2]n (1), [Zn(hepH)2Pd(μ-CN)2(CN)2]n (2) and [Cd(hepH)2Pd(μ-CN)2(CN)2]n (3) (2-pyridineethanol abbreviated to hepH), have been synthesized and characterized by various techniques (elemental analysis, FT-IR and Raman spectroscopy, thermal analysis and single crystal X-ray diffraction). FT-IR spectroscopy pointed out the existence of terminal and bridged cyanide ligands in the complexes. The crystallographic analyses reveal that complexes 1 and 2 crystallize in the triclinic system, space group P-1 and complex 3 crystallizes in the monoclinic system, space group P2₁/n. The palladium atom is coordinated with cyanide-carbon atoms in a square-planar arrangement and the metal(II) atoms are six-coordinated with two cyanide nitrogen, two hepH nitrogen and two hepH oxygen atoms, in a distorted octahedral arrangement. In all the complexes adjacent chains are connected by CH⋯Pd, π⋯π and OH⋯N hydrogen bonding interactions to form two- and three-dimensional networks. When it comes to thermal analysis, the complexes followed usual decomposition mechanism in which neutral ligands (hepH) are released first, and then cyanide ligands are decomposed. The final decomposition products are found to be the corresponding metal oxides.

Synthesis and characterization of new heterometallic cyanido complexes based on [Co(CN)6]3− building blocks: crystal structure of [Cu2(N-bishydeten)2Co(CN)6]·3H2O having a strong antiferromagnetic exchange

The hexacyanidocobalt(iii)-based four new coordination compounds have been synthesized and characterized by various techniques. The polymeric C2 having 148.3 ų lattice spacing among these complexes have shown very strong antiferromagnetic interaction.